Visible-light curable low-molecular-weight chitosan derivative (furfuryl low-molecular-weight chitosan, F-LMC) was prepared to reduce adhesion of inter-tissue after surgical operation. If unexpected adhesion is happened after surgical treatment, re-operation is needed because of reserve pains and inflammation reactions to patient. The adhesion that occurs after tendon-repair surgery results in fail to recover original strength of tendon. Recently, to minimizing these side effects, biomaterial barriers, nanofibrous, and gels are used. Chitosan is a natural polymer obtained from the deacetylation of chitin. Chitosan has biocompatibility, wound-healing effect, hemostatic activity, fungistatic, antitumor, anti-cholesteremic activities and biodegradable properties. Especially, β-foam chitosan that was already studied has the anti-bacterial activity than α-foam. High-molecular-weight chitosan is insoluble, while low-molecular-weight chitosan can be dissolved in water. In this study, low-molecular-weight chitosan was modified by introducing furfuryl group for photo-curing. We expect that F-LMC could prevent adhesion because F-LMC could make physical separation by coating the surgical surface. Structure of prepared F-LMC was analyzed using 1H-NMR and photo-reactive property of F-LMC was confirmed through micro-patterning. Also, for medical application, biocompatibility of F-LMC was evaluated by WST assay. In animal experiment, especially chicken model, prepared F-LMC showed improved anti-adhesive property than other groups. From these results, F-LMC could be developed as biocompatible anti-adhesion.